New York NY (PRWEB)
June 16, 2017
Anyone who has been diagnosed with cancer or who has known someone who has been diagnosed is aware of the mental, physical and emotional toll the disease will take through diagnosis and treatment. Ovarian cancer is no exception, and with more than 22,000 women in the U.S. projected to be diagnosed with ovarian cancer annually, there needs to be a better understanding of the disease. Ovarian cancer is the 5th leading cause of cancer death in American women.
A video accompanying this announcement is available at: https://youtu.be/_ZIDB_EZbCo
To identify the unmet education and support needs of the advanced ovarian cancer community, TESARO developed the Our Way Forward survey, with input from the National Ovarian Cancer Coalition (NOCC) and the Ovarian Cancer Research Fund Alliance (OCRFA); the organizations helped promote the survey to patients and oncologists. This national survey found regardless of the stage of ovarian cancer, there is uncertainty among patients about what to expect after diagnosis – whether they are initially diagnosed or actively seeking greater resources and connections to lessen the burden of the disease.
In conjunction with D S Simon Media and YourUpdate.TV, Tesaro Inc. worked with Stephanie V. Blank, MD, Professor in the Division of Gynecologic Oncology, Department of Obstetrics, Gynecology and Reproductive Science, Icahn School of Medicine at Mount Sinai, and Director of Women’s Health, Mount Sinai Downtown-Chelsea Center and Anne Sweeney, Massachusetts Chapter Manager, National Ovarian Cancer Coalition, wife, mother and ovarian cancer thriver on a media tour to bring awareness to the Our Way Forward campaign.
Dr. Blank and Anne spoke to television and radio stations across the country and were able to address:
- Why the treatment experience of advanced ovarian cancer is full of anxiety…